» Articles » PMID: 38003376

Role and Regulation of Transcription Factors in Osteoclastogenesis

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2023 Nov 25
PMID 38003376
Authors
Affiliations
Soon will be listed here.
Abstract

Bones serve mechanical and defensive functions, as well as regulating the balance of calcium ions and housing bone marrow.. The qualities of bones do not remain constant. Instead, they fluctuate throughout life, with functions increasing in some situations while deteriorating in others. The synchronization of osteoblast-mediated bone formation and osteoclast-mediated bone resorption is critical for maintaining bone mass and microstructure integrity in a steady state. This equilibrium, however, can be disrupted by a variety of bone pathologies. Excessive osteoclast differentiation can result in osteoporosis, Paget's disease, osteolytic bone metastases, and rheumatoid arthritis, all of which can adversely affect people's health. Osteoclast differentiation is regulated by transcription factors NFATc1, MITF, C/EBPα, PU.1, NF-κB, and c-Fos. The transcriptional activity of osteoclasts is largely influenced by developmental and environmental signals with the involvement of co-factors, RNAs, epigenetics, systemic factors, and the microenvironment. In this paper, we review these themes in regard to transcriptional regulation in osteoclastogenesis.

Citing Articles

Osteoclast Activation and Inflammatory Bone Diseases: Focusing on Receptors in Osteoclasts.

Zhao W, Li J, Su T, Wang C, Fu Y, Li C J Inflamm Res. 2025; 18:3201-3213.

PMID: 40059949 PMC: 11890017. DOI: 10.2147/JIR.S507269.


Regulation of histone H3K27 methylation in inflammation and cancer.

Ma J, Zhang Y, Li J, Dang Y, Hu D Mol Biomed. 2025; 6(1):14.

PMID: 40042761 PMC: 11882493. DOI: 10.1186/s43556-025-00254-x.


Hyperbaric oxygen potentiates platelet-rich plasma composition and accelerates bone healing.

Chang W, Huang C, Chen T, Chao S, Lin C, Chang C J Orthop Translat. 2025; 51:1-12.

PMID: 39902098 PMC: 11787568. DOI: 10.1016/j.jot.2024.10.016.


Immunotherapy in the Battle Against Bone Metastases: Mechanisms and Emerging Treatments.

Hamza F, Mohammad K Pharmaceuticals (Basel). 2025; 17(12.

PMID: 39770433 PMC: 11679356. DOI: 10.3390/ph17121591.


Methotrexate inhibits glucocorticoids-induced osteoclastogenesis via activating IFN-γR/STAT1 pathway in the treatment of rheumatoid arthritis.

Teng Y, Yin H, Feng R, Jiang L, Qiu W, Duan X RMD Open. 2024; 10(4).

PMID: 39510764 PMC: 11552566. DOI: 10.1136/rmdopen-2024-004886.


References
1.
Blixt N, Faulkner B, Astleford K, Lelich R, Schering J, Spencer E . Class II and IV HDACs function as inhibitors of osteoclast differentiation. PLoS One. 2017; 12(9):e0185441. PMC: 5617211. DOI: 10.1371/journal.pone.0185441. View

2.
Thommesen L, Stunes A, Monjo M, Grosvik K, Tamburstuen M, Kjobli E . Expression and regulation of resistin in osteoblasts and osteoclasts indicate a role in bone metabolism. J Cell Biochem. 2006; 99(3):824-34. DOI: 10.1002/jcb.20915. View

3.
Wang Q, Wu Q . Knockdown of receptor interacting protein 140 (RIP140) alleviated lipopolysaccharide-induced inflammation, apoptosis and permeability in pulmonary microvascular endothelial cells by regulating C-terminal binding protein 2 (CTBP2). Bioengineered. 2022; 13(2):3981-3992. PMC: 8973626. DOI: 10.1080/21655979.2022.2031403. View

4.
Wu S, Liang Q, Liu Y, Cui R, Yuan L, Liao E . Omentin-1 Stimulates Human Osteoblast Proliferation through PI3K/Akt Signal Pathway. Int J Endocrinol. 2013; 2013:368970. PMC: 3626246. DOI: 10.1155/2013/368970. View

5.
Siddiqui J, Partridge N . Physiological Bone Remodeling: Systemic Regulation and Growth Factor Involvement. Physiology (Bethesda). 2016; 31(3):233-45. PMC: 6734079. DOI: 10.1152/physiol.00061.2014. View